| Identification | Back Directory | [Name]
4,4-DIFLUORO-D-PROLINAMIDE HYDROCHLORIDE | [CAS]
1315053-41-8 | [Synonyms]
4,4-DIFLUORO-D-PROLINAMIDE HYDROCHLORIDE (2R)-4,4-difluoropyrrolidine-2-carboxamide (R)-4,4-difluoropyrrolidine-2-carboxamide HCl (R)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride 2-Pyrrolidinecarboxamide, 4,4-difluoro-, hydrochloride (1:1), (2R)- | [Molecular Formula]
C5H9ClF2N2O | [MDL Number]
MFCD06797015 | [MOL File]
1315053-41-8.mol | [Molecular Weight]
186.59 |
| Chemical Properties | Back Directory | [storage temp. ]
Sealed in dry,Room Temperature | [form ]
solid | [InChI]
1S/C5H8F2N2O.ClH/c6-5(7)1-3(4(8)10)9-2-5;/h3,9H,1-2H2,(H2,8,10);1H/t3-;/m1./s1 | [InChIKey]
RRQDQYAEZGKHOB-AENDTGMFSA-N | [SMILES]
NC([C@@H]1NCC(F)(F)C1)=O.Cl |
|
| Company Name: |
BTC Pharmaceutical CO. Ltd
|
| Tel: |
+86-15716293042;0513-68015397;15716293042 18862997610;18862996710 |
| Website: |
http://www.btcpharm.com |
|